| Identification and characterization of a ouabain-like compound from human plasma. JM Hamlyn, MP Blaustein, S Bova, DW DuCharme, DW Harris, F Mandel, ... Proceedings of the National Academy of Sciences 88 (14), 6259-6263, 1991 | 1027 | 1991 |
| Mass spectral characterization of an endogenous digitalislike factor from human plasma. WR Mathews, DW DuCharme, JM Hamlyn, DW Harris, F Mandel, ... Hypertension 17 (6_pt_2), 930-935, 1991 | 273 | 1991 |
| Purification of an endogenous digitalislike factor from human plasma for structural analysis. JH Ludens, MA Clark, DW DuCharme, DW Harris, BS Lutzke, F Mandel, ... Hypertension 17 (6_pt_2), 923-929, 1991 | 209 | 1991 |
| (S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D4 Antagonist RE TenBrink, CL Bergh, JN Duncan, DW Harris, RM Huff, RA Lahti, ... Journal of medicinal chemistry 39 (13), 2435-2437, 1996 | 124 | 1996 |
| Development of an immunoassay for endogenous digitalislike factor. DW Harris, MA Clark, JF Fisher, JM Hamlyn, KP Kolbasa, JH Ludens, ... Hypertension 17 (6_pt_2), 936-943, 1991 | 120 | 1991 |
| Digitalis-like activity in human plasma: purification, affinity, and mechanism JM Hamlyn, DW Harris, JH Ludens Journal of Biological Chemistry 264 (13), 7395-7404, 1989 | 117 | 1989 |
| Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. KM Merchant, GS Gill, DW Harris, RM Huff, MJ Eaton, K Lookingland, ... Journal of Pharmacology and Experimental Therapeutics 279 (3), 1392-1403, 1996 | 115 | 1996 |
| Effects of an endogenous ouabainlike compound on heart and aorta. S Bova, MP Blaustein, JH Ludens, DW Harris, DW DuCharme, JM Hamlyn Hypertension 17 (6_pt_2), 944-950, 1991 | 99 | 1991 |
| Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors AA Miller, GL Bundy, JE Mott, JE Skepner, TP Boyle, DW Harris, ... Antimicrobial agents and chemotherapy 52 (8), 2806-2812, 2008 | 89 | 2008 |
| Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo S Thaisrivongs, DT Pals, DW Harris, WM Kati, SR Turner Journal of medicinal chemistry 29 (10), 2088-2093, 1986 | 87 | 1986 |
| Determination of biological activity of alprazolam, triazolam and their metabolites VH Sethy, DW Harris Journal of Pharmacy and Pharmacology 34 (2), 115-116, 1982 | 86 | 1982 |
| An orally active inhibitor of renin. DT Pals, S Thaisrivongs, JA Lawson, WM Kati, SR Turner, GL DeGraaf, ... Hypertension 8 (12), 1105-1112, 1986 | 85 | 1986 |
| Effect of norepinephrine uptake blocker on β-adrenergic receptors of the rat cerebral cortex VH Sethy, DW Harris European journal of Pharmacology 75 (1), 53-56, 1981 | 64 | 1981 |
| . alpha.-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model S Thaisrivongs, DT Pals, JA Lawson, SR Turner, DW Harris Journal of medicinal chemistry 30 (3), 536-541, 1987 | 57 | 1987 |
| Isolation and characterization of a sodium pump inhibitor from human plasma. JM Hamlyn, DW Harris, MA Clark, AC Rogowski, RJ White, JH Ludens Hypertension 13 (6_pt_2), 681-689, 1989 | 50 | 1989 |
| Synthesis of CDP-diglyceride from phosphatidylinositol and CMP M Hokin-Neaverson, K Sadeghian, DW Harris, JS Merrin Biochemical and Biophysical Research Communications 78 (1), 364-371, 1977 | 40 | 1977 |
| High affinity binding of [3H] ethylketocyclazocine to rat brain homogenate DW Harris, VH Sethy European Journal of Pharmacology 66 (1), 121-123, 1980 | 39 | 1980 |
| Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth DM Brown, H Williams, KJP Ryan, TL Wilson, ZCTR Daniel, MHD Mareko, ... Scientific reports 6 (1), 28693, 2016 | 38 | 2016 |
| 1-(Alkylamino) isochromans: hypotensives with peripheral and central activities JM McCall, RB McCall, RE TenBrink, BV Kamdar, SJ Humphrey, ... Journal of Medicinal Chemistry 25 (1), 75-81, 1982 | 28 | 1982 |
| Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. RB McCall, AG Romero, MJ Bienkowski, DW Harris, JC McGuire, ... The Journal of pharmacology and experimental therapeutics 271 (2), 875-883, 1994 | 26 | 1994 |
